Here’s the latest on the news about a common back‑pain drug that may be linked to an increased risk of dementia:
🧠 What the research found
📌 A large observational study looked at adults with chronic low back pain and found that people who were prescribed Gabapentin repeatedly were more likely to be diagnosed with dementia or mild cognitive impairment (MCI) than similar patients not given the drug.
- Those with 6 or more prescriptions had up to a 29 % higher risk of dementia and an 85 % higher risk of mild cognitive problems within about a decade compared with peers who didn’t take it.
This suggestion comes from analysis of tens of thousands of medical records — not just one small trial — and was published in a reputable medical journal.
📊 Important nuance about the findings
- Correlation vs. causation: The study observes an association between gabapentin use and later dementia diagnoses — it does not prove the drug causes dementia. Other factors (like severity of pain or inactivity) could also contribute.
- The increased risk appeared more pronounced in non‑elderly adults, including middle‑aged people in the study.
🩺 What experts say
- Some clinicians are cautious because gabapentin is widely used off‑label for pain, sleep, anxiety, and other conditions, even though cognitive decline isn’t currently a listed side effect.
- More research is needed to confirm these associations and understand mechanisms.
🤔 Should you stop taking it?
No — do not stop or change medications on your own.
If you take gabapentin:
- Talk to your doctor before stopping or switching.
- Discuss your overall dementia risk and whether alternative pain treatments might be appropriate.
If you’d like, I can explain why gabapentin is so commonly used for back pain, and what safer alternative options doctors might consider — just ask!
